Safety and Tolerability of ACU-4429

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.

Key facts

Study ID

NCT00703183

Run by

Kubota Vision Inc.

People needed

46

Starts

2008-05-01

Expected to finish

2009-06-01

Last updated by the study team

2012-06-27

Who can join

Age: 55 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Is male or female with age ≥ 55 and ≤ 80 years at the time of consent
• Is healthy as determined by medical history and physical examination

You may not qualify if…

• Is receiving or has recently received treatment with a medication disallowed per the protocol

Where it is running

• Covance Clinical Research Unit, Inc — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.